FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

816411000001106: Nolvadex 10mg tablets (AstraZeneca) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16576501000001115 Nolvadex 10mg tablets (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54076401000001117 Nolvadex 10mg tablets (AstraZeneca UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nolvadex 10mg tablets (AstraZeneca) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Is a Product containing precisely tamoxifen 10 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Is a Tamoxifen 10mg tablets true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Is a Tamoxifen 10mg tablets false Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has active ingredient Tamoxifen citrate false Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has active ingredient Tamoxifen false Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Is a Nolvadex true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tamoxifen true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has specific active ingredient Tamoxifen citrate true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) Has basis of strength substance Tamoxifen true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nolvadex 10mg tablets (AstraZeneca) 30 tablet 3 x 10 tablets Is pack of False Nolvadex 10mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier
Nolvadex 10mg tablets (AstraZeneca) 30 tablet 3 x 10 tablets Has AMP True Nolvadex 10mg tablets (AstraZeneca) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start